Cargando…
Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA
BACKGROUND: West Nile virus is an emerging human pathogen for which specific antiviral therapy has not been developed. Recent studies have suggested that RNA interference (RNAi) has therapeutic potential as a sequence specific inhibitor of viral infection. Here, we examine the ability of exogenous s...
Autores principales: | Geiss, Brian J, Pierson, Theodore C, Diamond, Michael S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174879/ https://www.ncbi.nlm.nih.gov/pubmed/15985182 http://dx.doi.org/10.1186/1743-422X-2-53 |
Ejemplares similares
-
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
por: Nelson, Steevenson, et al.
Publicado: (2008) -
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide
por: Nakamura, Momoko, et al.
Publicado: (2022) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013) -
Polymers in the Delivery of siRNA for the Treatment of Virus Infections
por: Reynolds, Nicholas, et al.
Publicado: (2017)